Discover 3,592 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,592
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
for
Recurrent or Metastatic Solid Tumors
Location: Newport Beach CA, Las Vegas NV, Nashville TN,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07015697
Phase 1, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Newport Beach CA, Garden Grove CA, Torrance CA,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Newport Beach CA, Torrance CA, Fresno CA, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Newport Beach CA, Garden Grove CA, Mission Viejo CA,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase 3, Recruiting
New
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC
for
Functional Constipation (FC)
Location: Anaheim CA, Paramount CA, Gresham OR, San Antonio TX,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 6 - 17
Code: NCT07723924
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
for
Agitation Associated With Alzheimer's Dementia
Location: Anaheim CA, Las Vegas NV, San Antonio TX, Tampa FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06651567
Phase 2, Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Location: Anaheim CA, West Covina CA, Garden Grove CA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06229210
Phase 3, Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
for
Attention-Deficit/Hyperactivity Disorder
Location: Anaheim CA, Long Beach CA, Imperial CA, Las Vegas NV,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 4 - 5
Code: NCT04781140
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for
Pneumococcal Disease
Location: Anaheim CA, Bellflower CA, El Monte CA, Montebello CA,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07629440
Phase 3, Recruiting
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
for
Schizophrenia, Autism-Related Irritability
Location: Anaheim CA, Chino CA, Culver City CA, San Francisco CA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 5 - 17
Code: NCT07424404
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
for
Schizophrenia
Location: Anaheim CA, Chino CA, Culver City CA, San Francisco CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 13 - 17
Code: NCT07288567
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for
Alzheimer Disease
Location: Anaheim CA, Pomona CA, Las Vegas NV, Scottsdale AZ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011732
Phase 3, Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
for
Irritability Associated With Autism Spectrum Disorder
Location: Anaheim CA, West Covina CA, Redlands CA, Oceanside CA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06690398
Phase 3, Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
for
Psychotic Disorders, Alzheimer Disease
Location: Anaheim CA, Walnut Creek CA, Bellevue WA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06540833
Phase 2, Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for
Psychosis Associated With Alzheimer's Disease
Location: Anaheim CA, Pasadena CA, Los Angeles CA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT05980949
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Anaheim CA, Fountain Valley CA, Costa Mesa CA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Anaheim CA, Long Beach CA, Pomona CA, La Jolla CA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Fountain Valley CA, Santa Rosa CA, West Valley City UT,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH